Harding Loevner LP Haleon PLC Transaction History

Harding Loevner LP

$13.2 Billion
Q3 2025

A detailed history of Harding Loevner LP transactions in Haleon PLC stock. As of the latest transaction made, Harding Loevner LP holds 17,909,401 shares of HLN stock, worth $172 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

17,909,401

Previous 22,551,041 20.58%

Holding current value

$172 Million

Previous $234 Million 31.3%

% of portfolio

1.22%

Previous 1.62%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$8.72 - $10.35 $40.5 Million - $48 Million	-4,641,640 Reduced 20.58%	17,909,401 $161 Million
Q2 2025 Aug 14, 2025	SELL	$9.27 - $11.41 $4.83 Million - $5.94 Million	-520,880 Reduced 2.26%	22,551,041 $234 Million
Q1 2025 May 15, 2025	SELL	$9.02 - $10.67 $9.51 Million - $11.3 Million	-1,054,421 Reduced 4.37%	23,071,921 $237 Million
Q4 2024 Feb 14, 2025	SELL	$9.23 - $10.71 $7.03 Million - $8.16 Million	-761,666 Reduced 3.06%	24,126,342 $231 Million
Q3 2024 Nov 14, 2024	SELL	$8.32 - $10.7 $6.05 Million - $7.77 Million	-726,619 Reduced 2.84%	24,888,008 $263 Million
Q2 2024 Aug 14, 2024	BUY	$8.01 - $8.64 $182 Million - $196 Million	22,706,901 Added 780.92%	25,614,627 $212 Million
Q1 2024 May 15, 2024	SELL	$8.02 - $8.67 $156 Million - $169 Million	-19,464,464 Reduced 87.0%	2,907,726 $24.7 Million
Q4 2023 Feb 14, 2024	SELL	$7.78 - $8.62 $863,564 - $956,802	-110,998 Reduced 0.49%	22,372,190 $184 Million
Q3 2023 Nov 14, 2023	BUY	$7.85 - $8.94 $72.4 Million - $82.5 Million	9,222,814 Added 69.55%	22,483,188 $187 Million
Q2 2023 Aug 14, 2023	BUY	$8.04 - $9.0 $28.6 Million - $32 Million	3,554,361 Added 36.62%	13,260,374 $111 Million
Q1 2023 May 15, 2023	BUY	$7.57 - $8.37 $73.5 Million - $81.2 Million	9,706,013 New	9,706,013 $79 Million

Others Institutions Holding HLN

# of Institutions

683

Shares Held

451M

Call Options Held

114K

Put Options Held

25.7K

View Full List

About Haleon plc

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.3B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

More about HLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.

Account

Harding Loevner LP Haleon PLC Transaction History